Accolades
Sidley’s Global Life Sciences Practice Recognized in LMG Life Sciences 2025
October 1, 2025
Sidley was recognized as a Life Cycle Firm for the fifth consecutive year by LMG Life Sciences. The designation recognizes a select group of law firms with the depth and breadth to handle legal issues across the entire life span of a life sciences product.
Overall, Sidley received 11 practice rankings and 29 lawyer rankings in the 2025 edition of LMG Life Sciences. The firm was ranked in:
- Antitrust
- Corporate
- FDA: Medical Device
- FDA: Pharmaceutical
- General Patent Litigation
- Hatch-Waxman Patent Litigation (Branded)
- Healthcare Pricing & Reimbursement
- Licensing & Collaboration
- Mergers & Acquisitions
- Product Liability
- White-Collar/Government Investigation
The annual LMG Life Sciences guide highlights North America’s leading firms and lawyers serving the life sciences industry, with rankings across finance, regulation, and litigation.
得意分野
Suggested News & Insights
Sidley Represents Passport Global in Its US$425 Million Agreement to Be Acquired by Global-e (Nasdaq: GLBE)May 27, 2026May Antitrust and Competition Bulletin: Top-of-Mind Global Antitrust IssuesMay 21, 2026Sidley Represents IMA Financial Group in Equity Recapitalization TransactionMay 19, 2026Sidley Represents Rigel Pharmaceuticals in Exclusive Global License Agreement with Pfizer and Arvinas for VEPPANUMay 13, 2026Sidley Represents Private Equity at Goldman Sachs Alternatives in the Acquisition of FGI WorldwideMay 12, 2026When “The Devil Made Me Do It” Is Not a Defense: Lessons in AI Governance and Organizational Oversight from an SDNY DecisionMay 11, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory